Cancer Diagnostics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
304
NCT06446882
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
Phase: N/A
Role: Collaborator
Start: Oct 11, 2024
Completion: Nov 30, 2028
Loading map...